Scarica l'app Stockscreener
0.00
100.00%
-17.11
Veraxa Biotech Ag Borsa (VACH) Ultime notizie
VRXA|Veraxa Biotech AG Ord Shs|Price:2.910|Chg%:-1.23 - TradingKey
Veraxa Biotech AG Ord Shs (VRXA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
VRXA|Veraxa Biotech AG Ord Shs|Price:3.440|Chg%:-0.70 - TradingKey
VERAXA Biotech (VRXA) Showcases BiTAC Cancer Platforms Ahead of BIO International Convention - NewMediaWire
VERAXA Biotech Seeks Partners for BiTAC Cancer Platforms at BIO International Convention - MEXC
VERAXA Biotech to Showcase BiTAC Cancer Platforms at BIO International Convention - citybuzz -
VERAXA Biotech (NASDAQ: VRXA) Showcases BiTAC Cancer Platforms Ahead of BIO International Convention - The Globe and Mail
VERAXA Biotech (VRXA) Reports Proof-of-Concept Data for BiTAC-ADC Cancer Therapy Platform - NewMediaWire
Appleby Advises Voyager Acquisition Corp. In Its Business Combination With Veraxa Biotech AG - Mondaq
symbol__ Stock Quote Price and Forecast - CNN
Veraxa Biotech reports data on BiTAC-ADC cancer platform By Investing.com - Investing.com Canada
VERAXA Biotech (NASDAQ: VRXA) Reports Proof-of-Concept Data for BiTAC-ADC Cancer Therapy Platform - USA Today
VRXA SEC FilingsVeraxa Biotech AG 10-K, 10-Q, 8-K Forms - Stock Titan
VERAXA Biotech Reports Proof-of-Concept Data for Tumor-Restricted BiTAC-ADC Cancer Therapy Platform - citybuzz -
Veraxa Biotech reports data on BiTAC-ADC cancer platform - Investing.com
VERAXA Unveils Cancer Therapy Platform, Sparks Partnering Talks at BIO 2026 - Yahoo Finance
VERAXA’s cancer therapy platform clears lab test, seeks partners - Stock Titan
VERAXA Biotech AG: Advancing Next-Generation Antibody-Based Cancer Therapies - citybuzz -
Why VERAXA Biotech AG (NASDAQ: VRXA) Is ‘One to Watch’ - The Globe and Mail
Why VERAXA Biotech AG (VRXA) Is 'One to Watch' - Yahoo Finance
Veraxa Biotech: Post-Merger Valuation Does Not Match The Risk - Seeking Alpha
[20-F] Veraxa Biotech Holding AG Files Annual Report (Foreign Issuer) | VRXA SEC FilingForm 20-F - Stock Titan
European Molecular Biology Laboratory discloses 16.2% VRXA stake after SPAC merger - Stock Titan
Veraxa Biotech (VRXA) holder discloses 18% stake and VWAP earnout - Stock Titan
VERAXA Biotech AG’s Diversified Oncology Pipeline Positions It as a Company to Watch - citybuzz -
VRXA - Finviz
Veraxa Biotech Holding (VRXA) Stock Analysis Report | Financials & Insights - Benzinga
Veraxa Biotech Holding (VRXAW) Stock Analysis Report | Financials & Insights - Benzinga
Xlife Sciences discloses 16.3% Veraxa (VRXA) stake after business combination - Stock Titan
Major Veraxa (VRXA) shareholder reports 15.9% stake and potential 5M earnout shares - Stock Titan
Number of employees of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Veraxa Biotech AG Financial Statements – NASDAQ:VRXAW - TradingView
Current ratio of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
All News for VRXA : Veraxa Biotech AG - Zacks Investment Research
Veraxa Biotech AG Earnings and Revenue – NASDAQ:VRXA - TradingView
Net debt of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Basic earnings per share (basic EPS) of Veraxa Biotech AG – BOATS:VRXA - TradingView
Operating expenses (excl. COGS) of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
Debt to assets ratio of Veraxa Biotech AG – BOATS:VRXAW - TradingView
Price to book ratio of Veraxa Biotech AG – BOATS:VRXAW - TradingView
EBITDA per share of Veraxa Biotech AG – BOATS:VRXAW - TradingView
VERAXA Biotech (NASDAQ: VRXA) Is ‘One to Watch’ - The Globe and Mail
Operating cash flow per share of Veraxa Biotech AG – BOATS:VRXA - TradingView
Return on equity % of Veraxa Biotech AG – BOATS:VRXAW - TradingView
Return on invested capital % of Veraxa Biotech AG – BOATS:VRXAW - TradingView
Total common shares outstanding of Veraxa Biotech AG – BOATS:VRXAW - TradingView
Total equity of Veraxa Biotech AG – BOATS:VRXAW - TradingView
Gross margin % of Veraxa Biotech AG – BOATS:VRXAW - TradingView
Net margin % of Veraxa Biotech AG – BOATS:VRXAW - TradingView
Price to sales ratio of Veraxa Biotech AG – BOATS:VRXAW - TradingView
Net debt of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
Total liabilities & shareholders' equities of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
Should I buy Veraxa Biotech AG (VRXA) - Zacks Investment Research
EBIT per share of Veraxa Biotech AG – BOATS:VRXA - TradingView
Gross profit of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
Dilution adjustment of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
Non-controlling/minority interest of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
Diluted shares outstanding of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
EBIT of Veraxa Biotech AG – BOATS:VRXAW - TradingView
Total debt of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
Diluted net income available to common stockholders of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
Veraxa Biotech AG Balance Sheet – BOATS:VRXAW - TradingView
Total revenue of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
Total operating expenses of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
Price to earnings ratio of Veraxa Biotech AG – BOATS:VRXAW - TradingView
Operating income of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
EBIT of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
Diluted earnings per share (diluted EPS) of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
Enterprise value to EBITDA ratio of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
After tax other income/expense of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
EBITDA of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
Net margin % of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Veraxa Biotech AG (VRXA) Cash From Operations (TTM) - Zacks Investment Research
0.45%
2.99%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):